Sub-Total: $0.00
New Era in the Lipid Lowering Treatment with PCSK9 Inhibitors (Evolocumab and Alirocumab) in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia
Complimentary
Related products
-
Advances in Biological Therapies for Atopic Dermatitis in Adults and Children
Read more -
New Paradigms in the Management of Hereditary Transthyretin Amyloidosis Mixed Phenotype (ATTRv): ATTRv-CM and ATTRv-PN
Read more -
New Paradigms in the Treatment and Management of Neovascular Age-related Macular Degeneration (nAMD)
Read more -
MGD-Associated Dry Eye Disease: Pathophysiology, Current and Emerging Therapies for Improved Outcomes
Read more
